BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Price ER, Wong J, Mukhtar R, Hylton N, Esserman LJ. How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer. World J Clin Cases 2015; 3(7): 607-613 [PMID: 26244152 DOI: 10.12998/wjcc.v3.i7.607]
URL: https://www.wjgnet.com/2218-4333/full/v3/i7/607.htm
Number Citing Articles
1
Erika Marina Solla Negrão, Almir Galvão Vieira Bitencourt, Juliana Alves de Souza, Elvira Ferreira Marques. Accuracy of breast magnetic resonance imaging in evaluating the response to neoadjuvant chemotherapy: a study of 310 cases at a cancer centerRadiologia Brasileira 2019; 52(5): 299 doi: 10.1590/0100-3984.2018.0149
2
Niketa Chotai, Supriya Kulkarni. Breast Imaging Essentials2020; : 111 doi: 10.1007/978-981-15-1412-8_15
3
Marie-Pierre Chauvet. Nouvelle chirurgie du cancer du seinLa Presse Médicale 2019; 48(10): 1123 doi: 10.1016/j.lpm.2019.08.020
4
Devan Diwanji, Natsuko Onishi, Deep K. Hathi, Courtney Lawhn-Heath, John Kornak, Wen Li, Ruby Guo, Julissa Molina-Vega, Youngho Seo, Robert R. Flavell, Diane Heditsian, Susie Brain, Laura J. Esserman, Bonnie N. Joe, Nola M. Hylton, Ella F. Jones, Kimberly M. Ray. 18F-FDG Dedicated Breast PET Complementary to Breast MRI for Evaluating Early Response to Neoadjuvant ChemotherapyRadiology: Imaging Cancer 2024; 6(2) doi: 10.1148/rycan.230082
5
M. P. Chauvet, A. Mailliez. Chimiothérapie néoadjuvante : pour qui ?Oncologie 2016; 18(2-3): 115 doi: 10.1007/s10269-016-2590-z
6
Nathaniel M. Braman, Maryam Etesami, Prateek Prasanna, Christina Dubchuk, Hannah Gilmore, Pallavi Tiwari, Donna Plecha, Anant Madabhushi. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRIBreast Cancer Research 2017; 19(1) doi: 10.1186/s13058-017-0846-1
7
Yanding Zhao, Evelien Schaafsma, Chao Cheng. Gene signature‐based prediction of triple‐negative breast cancer patient response to Neoadjuvant chemotherapyCancer Medicine 2020; 9(17): 6281 doi: 10.1002/cam4.3284
8
Erika M.S. Negrão, Juliana A. Souza, Elvira F. Marques, Almir G.V. Bitencourt. Breast cancer phenotype influences MRI response evaluation after neoadjuvant chemotherapyEuropean Journal of Radiology 2019; 120: 108701 doi: 10.1016/j.ejrad.2019.108701
9
K. K. Rajan, C. Boersma, M. A. Beek, T. A. Berendsen, J. van der Starre-Gaal, M. van ’t Veer-ten Kate, A. B. Francken, E. M. Noorda. Optimizing surgical strategy in locally advanced breast cancer: a comparative analysis between preoperative MRI and postoperative pathology after neoadjuvant chemotherapyBreast Cancer Research and Treatment 2024; 203(3): 477 doi: 10.1007/s10549-023-07122-8
10
Yireh Han, Ji Gwang Jung, Jang-il Kim, Changjin Lim, Hong-Kyu Kim, Han-Byoel Lee, Hyeong-Gon Moon, Wonshik Han. The percentage of unnecessary mastectomy due to false size prediction using preoperative ultrasonography and MRI in breast cancer patients who underwent neoadjuvant chemotherapy: a prospective cohort studyInternational Journal of Surgery 2023; 109(12): 3993 doi: 10.1097/JS9.0000000000000754
11
P. Taourel, E. Pages, I. Millet, C. Bourgier, P. Rouanet, W. Jacot, P. Crochet, D. Azria. Magnetic resonance imaging in breast cancer management in the context of neo-adjuvant chemotherapyCritical Reviews in Oncology/Hematology 2018; 132: 51 doi: 10.1016/j.critrevonc.2018.09.012
12
Zhenyu Liu, Zhuolin Li, Jinrong Qu, Renzhi Zhang, Xuezhi Zhou, Longfei Li, Kai Sun, Zhenchao Tang, Hui Jiang, Hailiang Li, Qianqian Xiong, Yingying Ding, Xinming Zhao, Kun Wang, Zaiyi Liu, Jie Tian. Radiomics of Multiparametric MRI for Pretreatment Prediction of Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter StudyClinical Cancer Research 2019; 25(12): 3538 doi: 10.1158/1078-0432.CCR-18-3190
13
Caitlin Murphy, Violet Mukaro, Robert Tobler, Rebecca Asher, Emma Gibbs, Linda West, Bruno Giuffre, Sally Baron‐Hay, Mustafa Khasraw. Evaluating the role of magnetic resonance imaging post‐neoadjuvant therapy for breast cancer in the NEONAB trialInternal Medicine Journal 2018; 48(6): 699 doi: 10.1111/imj.13617
14
Hongyi Dammu, Thomas Ren, Tim Q. Duong, Sriparna Saha. Deep learning prediction of pathological complete response, residual cancer burden, and progression-free survival in breast cancer patientsPLOS ONE 2023; 18(1): e0280148 doi: 10.1371/journal.pone.0280148
15
H. Cain, I.R. Macpherson, M. Beresford, S.E. Pinder, J. Pong, J.M. Dixon. Neoadjuvant Therapy in Early Breast Cancer: Treatment Considerations and Common Debates in PracticeClinical Oncology 2017; 29(10): 642 doi: 10.1016/j.clon.2017.06.003
16
Rita A. Mukhtar, Harrison Chau, Hannah Woriax, Mara Piltin, Gretchen Ahrendt, Julia Tchou, Hongmei Yu, Qian Ding, Catherine Lu Dugan, Jori Sheade, Angelena Crown, Michael Carr, Jasmine Wong, Jennifer Son, Rachel Yang, Theresa Chan, Alicia Terando, Michael Alvarado, Cheryl Ewing, Jennifer Tonneson, Nina Tamirisa, Rebekah Gould, Puneet Singh, Constantine Godellas, Kelsey Larson, Akiko Chiba, Roshni Rao, Candice Sauder, Lauren Postlewait, Marie Catherine Lee, William Fraser Symmans, Laura J. Esserman, Judy C. Boughey. Breast Conservation Surgery and Mastectomy Have Similar Locoregional Recurrence After Neoadjuvant ChemotherapyAnnals of Surgery 2023; 278(3): 320 doi: 10.1097/SLA.0000000000005968
17
Shahine Goulam-Houssein, Xiang Y. Ye, Rachel Fleming, Frederick Au, Supriya Kulkarni, Sandeep Ghai, Yoav Amitai, Michael Reedijk, Vivianne Freitas. Evaluating persistent T1-weighted lesions without concurrent abnormal enhancement on breast MRI in neoadjuvant chemotherapy patients: implications for complete pathological responseEuropean Radiology 2024;  doi: 10.1007/s00330-024-10695-7
18
Sherif Hassanien Ahmed. Safety of neoadjuvant chemotherapy for the treatment of breast cancerExpert Opinion on Drug Safety 2019; 18(9): 817 doi: 10.1080/14740338.2019.1644318